Staff Sub-Regional Marketing Business Partner - UK&I

England, United Kingdom

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Biotechnology, Genomic TechnologyIndustries

Requirements

Candidates should possess a bachelor's degree in Marketing, Biology, Biochemistry, or a related field. Proficiency in the full marketing mix, including VOC/VOS, multi-channel lead generation, and performance tracking is required. Significant experience in healthcare marketing, including customer segmentation, branding, content strategy, and digital engagement, is essential. The ability to thrive in complex, matrixed environments and influence without authority is crucial. Strong analytical, organizational, and data optimization skills are necessary.

Responsibilities

Develop and execute multi-channel marketing strategies tailored to healthcare customer segments across the UK, Ireland, and North regions. Conduct competitor analysis and market trend assessments to inform tactical programs. Collaborate with sales leaders to align portfolio strategy with customer needs. Plan and manage impactful in-person and digital events, and create customer-focused content and collateral. Own and manage the customer segment marketing budget, track campaign performance, lead generation, and ROI, and optimize omni-channel marketing programs. Align with sales, product, and regional marketing teams on launches and initiatives, and support sales enablement through tools and training. Drive messaging and tools for Biotech and Pharma customers, collaborate with market analysts on research programs, and provide regular training and insights to sales teams.

Skills

Healthcare Marketing

Marketing Strategy

Customer Segmentation

Branding

Content Strategy

Digital Marketing

Campaign Management

Cross-functional Collaboration

Strategic Planning

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free